Uri Ben-Or - 18 Mar 2026 Form 3 Insider Report for Scinai Immunotherapeutics Ltd. (SCNI)

Reporting relationship: Director
Issuer ticker: SCNI
Reported as of: 18 Mar 2026
Net transaction value: $0
SEC form: 3
Accepted by SEC: 18 Mar 2026, 10:06:28 UTC
Prior SEC filing: 03 Jan 2023
Source filing: View source filing
Reporting owner signature: /s/ Uri Ben-Or

Key filing fact

Uri Ben-Or filed Form 3 for Scinai Immunotherapeutics Ltd. (SCNI) on 18 Mar 2026.

Key facts

This page summarizes Uri Ben-Or's Form 3 filing for Scinai Immunotherapeutics Ltd. (SCNI).
0 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 18 Mar 2026, 10:06.

Change

Previous filing in this sequence was filed on 03 Jan 2023.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Official SEC source

Ownership activity is grounded in SEC Form 3 disclosures.

View source filing

Reporting Owners (1)

CIK 0001793464 Primary reporting owner

Ben-Or Uri

Relationship: Director
Address: C/O SCINAI IMMUNOTHERAPEUTICS LTD., JERUSALEM BIOPARK, 2ND FLOOR, JERUSALEM, ISRAEL
Signature: /s/ Uri Ben-Or
Signature date: 18 Mar 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

SCNI holding

Ordinary shares, no par value per share ("Ordinary Shares")

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 33,329,004
Date: 18 Mar 2026
Ownership: Direct
Footnotes: F1, F2, F3, F4

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

SCNI holding Derivative

American Depositary Shares

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date: 18 Mar 2026
Ownership: Direct
Underlying class: Ordinary Shares
Underlying amount: 2,519,344
Exercise price
Footnotes: F5

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 5 footnotes

Footnote F1

The Ordinary Shares are represented by American Depositary Shares, each of which currently represents four thousand Ordinary Shares.

Footnote F2

Includes 4,425,004 Ordinary Shares that are represented by restricted share units ("RSUs") that were granted on January 25, 2024, of which 25% vested on the six-month anniversary thereof, 8.33% vested on the 12-month anniversary thereof, and 66.66% vest in two equal annual installments thereafter, subject to the Reporting Person's continued service through such dates. Each RSU represents a contingent right to receive one Ordinary Share upon vesting.

Footnote F3

Includes 904,000 Ordinary Shares that are represented by RSUs that were granted on November 21, 2024, which vest in three equal annual installments thereafter, subject to the Reporting Person's continued service through such dates

Footnote F4

Includes 28,000,000 Ordinary Shares that are represented by RSUs that were granted on November 12, 2025, which vest in three equal annual installments thereafter, subject to the Reporting Person's continued service through such dates.

Footnote F5

Represents 630 American Depositary Shares, which are convertible at any time into 2,519,344 Ordinary Shares, at the holder's election and have no expiration date.

SEC remarks

Exhibit 24 - Power of Attorney.